Dr Steve Williams

Steve Williams joined SomaLogic 2009 as Chief Medical Officer. Steve trained as a physician at Charing Cross and Westminster medical school, University of London, and following his internships returned to the same institution for a PhD in medicine and physiology. He subsequently performed 3 years residency in diagnostic imaging at the University of Newcastle Upon Tyne. He joined Pfizer in the UK in 1989 in Experimental Medicine, and worked on a variety of programs including asthma, irritable bowel syndrome, migraine [eletriptan], depression [sertraline] and urinary incontinence [darifenacin]. He moved to the USA in 1993 still at Pfizer and worked in inflammatory bowel disease, stroke, psychosis [ziprasidone] and head-injury.

He created the Clinical Technology group in 1997, which became a worldwide function on 5 research sites with the objective of validating clinical biomarkers and measurements, and was made VP in 2006. In process initiatives, he led or co-led initiatives in diagnostics, biomarkers, quality of drug candidates and guidelines for development teams to make the decision to start phase III.